BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 954 filers reported holding BAXTER INTL INC in Q1 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $760,000 | +196.9% | 12,556 | +154.4% | 0.02% | +200.0% |
Q1 2017 | $256,000 | -77.7% | 4,936 | -81.0% | 0.01% | -75.0% |
Q4 2016 | $1,149,000 | +56.5% | 25,916 | +68.0% | 0.03% | +64.7% |
Q3 2016 | $734,000 | +95.2% | 15,430 | +85.7% | 0.02% | +112.5% |
Q2 2016 | $376,000 | -88.2% | 8,311 | -89.3% | 0.01% | -91.1% |
Q1 2016 | $3,196,000 | +302.5% | 77,791 | +273.8% | 0.09% | +542.9% |
Q4 2015 | $794,000 | -63.9% | 20,812 | -68.9% | 0.01% | -61.1% |
Q3 2015 | $2,198,000 | +27.5% | 66,901 | +171.3% | 0.04% | +16.1% |
Q2 2015 | $1,724,000 | +414.6% | 24,655 | +404.2% | 0.03% | +342.9% |
Q1 2015 | $335,000 | -57.4% | 4,890 | -54.4% | 0.01% | -46.2% |
Q4 2014 | $786,000 | +2.2% | 10,726 | +0.1% | 0.01% | -13.3% |
Q3 2014 | $769,000 | -50.1% | 10,718 | -49.7% | 0.02% | -37.5% |
Q2 2014 | $1,540,000 | -44.3% | 21,299 | -43.3% | 0.02% | -31.4% |
Q1 2014 | $2,764,000 | -46.9% | 37,558 | -49.8% | 0.04% | -38.6% |
Q4 2013 | $5,202,000 | +28.0% | 74,806 | +20.9% | 0.06% | +9.6% |
Q3 2013 | $4,065,000 | – | 61,879 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |